drugset

drugset / Trial / NCT01147003

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

NCT01147003 ↗

Phase 2 Completed 93 enrolled Novartis

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will assess the efficacy and safety of BGG492 as adjunctive treatment in patients with partial onset seizures.

Timeline

Start: 2010-06
Primary completion: 2011-09
Completion: 2011-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	selurampanel	Small molecule	—	—

Indications